Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT06372691
Other study ID # PoplitealApproach SciaticBlock
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date May 1, 2024
Est. completion date September 1, 2024

Study information

Verified date April 2024
Source Ankara City Hospital Bilkent
Contact Aysegül Özel Erdem
Phone 5549777289
Email aysegulozell@gmail.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The aim of this prospective, randomized, observer-blind study to compare subparaneural approach injection with interneural approach injection in popliteal sciatic nerve blocks.


Description:

The study will involve American Society of Anesthesiologists Physical Status Classification (ASA) III or IV risk group patients, 18 years of age or older, who will undergoing foot, ankle, or toe amputation. Supparaneural injection (Group S) and interneural injection method (Group I) will the two research groups to which patients were randomly allocated. Every 5 minutes following LA injection, an investigator who will blind to randomization will assess the sensory and motor blockage in the operated foot. The study will documented the operative time, block characteristics, such as the duration of block administration, sensory and motor block start and regression times, the time of extra analgesic required, and the occurrence of complications.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 809
Est. completion date September 1, 2024
Est. primary completion date August 1, 2024
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - 18 years and over - Planned foot, ankle or toe amputation - ASA III-IV risk group - Patients who agreed to be included in the study Exclusion Criteria: - People with neurological and psychiatric diseases - Using opioids or another analgesic for chronic pain - Allergic to local anesthetics - Pregnant or breastfeeding - Those with infection or sepsis in the application area - Patients who did not agree to be included in the study

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Subparaneural Injection (Grup S), Block
Comparison of two different methods in terms of various features
Interneural Injection (Grup I), Block
Comparison of two different methods in terms of various features

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Ankara City Hospital Bilkent

Outcome

Type Measure Description Time frame Safety issue
Primary Onset Time Onset time will be defined as the moment when it is determined that the block is successful. Time from the moment the block is made to the moment it starts, within the first half hour
Secondary Block Execution Times The time from the moment the block starts to the moment the transaction ends. 1-10 minutes
Secondary Need for Multiple Injections Owing to Insufficient Anesthesia How many blocks should be made. Within 24 hours
Secondary Additional Rescue Analgesic Analgesic use status. Within 24 hours
Secondary Adverse Effects to Anesthesia hypotension, agitation, nausea, vomiting, dizziness During the block period, within 24 hours
Secondary Hemodynamic Effects Of The Block Noninvasive systolic and diastolic blood pressure 0th minutes, 5th minutes,10th minutes,15th minutes,20th minutes,25th minutes,30th minutes,35th minutes,40th minutes,45th minutes,50th minutes,55th minutes and 60th minutes and then at 1-hour intervals and 15th minutes,30th minutes
Secondary Effects Of The Block On Heart Rate Heart rate 0th minutes, 5th minutes,10th minutes,15th minutes,20th minutes,25th minutes,30th minutes,35th minutes,40th minutes,45th minutes,50th minutes,55th minutes and 60th minutes and then at 1-hour intervals and 15th minutes,30th minutes
Secondary Effects Of The Block On Peripheral Pulse Oximetry Peripheral pulse oximetry 0th minutes, 5th minutes,10th minutes,15th minutes,20th minutes,25th minutes,30th minutes,35th minutes,40th minutes,45th minutes,50th minutes,55th minutes and 60th minutes and then at 1-hour intervals and 15th minutes,30th minutes
Secondary Regression Time Of Sensory and Motor Block When the block starts to come back. Within 24 hours
Secondary Total Block Times How long the block took in total. Within 24 hours
See also
  Status Clinical Trial Phase
Recruiting NCT06320626 - Pharmacokinetic-guided Dosing of Emicizumab Phase 4
Recruiting NCT05841667 - Impact of CES1 Genotype on Remimazolam
Completed NCT06355817 - Distraction Techniques in Periocular Anesthesia: Tapping vs Vibration N/A
Not yet recruiting NCT01209481 - Impact of Educational Group Intervention on the Consumption of Fruit and Vegetables N/A
Terminated NCT01570465 - Prospective Study on Severe Infections on Acute Myeloid Leukemia (AML) Patients
Completed NCT04169646 - Prevention and Intervention of Neck Pain in Swiss Office-Workers N/A
Not yet recruiting NCT01943565 - Intrathecal Hydromorphone for Post-cesarean Delivery Pain - a Dose Finding Study Phase 4
Completed NCT00519298 - Study Evaluating Effects of SAM-531 on Sleep Electroencephalogram (EEG) and Quantitative Wake EEG in Healthy Subjects Phase 1
Completed NCT03541837 - Erector Spinae Plane Block and Pain Management in Cardiac Surgery N/A
Active, not recruiting NCT00809575 - Quality of Life and Symptoms in Patients With Newly Diagnosed Myelodysplastic Syndromes
Completed NCT06383117 - Understanding Effects of Calcium on the Gut-Bone Axis N/A
Completed NCT05012046 - Effect of 100% Orange Juice on Food Intake and Glycemic Response in Adults N/A
Completed NCT05597969 - The Effect of an Application-based Health Intervention (FoodCoach) on Food Purchases in Switzerland N/A
Terminated NCT01817153 - Effect of Hydrocortison on Post-ischemic Flow-mediated Dilation and on Thenar Oxygen Saturation in Human Septic Shock. Phase 2/Phase 3
Not yet recruiting NCT05123352 - Investigation of the Gut Microbiota in Acute Myeloid Leukemia Receiving Two Different Induction Therapies
Not yet recruiting NCT03728114 - Effects of RIC on Cognitive Function and Blood Oxygen Levels in Unacclimatized Adult at High Altitude N/A
Completed NCT01162863 - Effects of Lubiprostone on Gastrointestinal Transit & pH in Irritable Bowel Syndrome (IBS) With Constipation N/A
Completed NCT05570435 - Efficacy of Milk Product Supplemented With Bioactives in Lowering Post Meal Glucose Response N/A
Recruiting NCT03713931 - PUMA Implementation 2
Completed NCT04443231 - Prospective Clinical Study of Retinal Microvascular Alteration After ICL Implantation